Note 9 - Income Taxes |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2020 | |||
Notes to Financial Statements | |||
Income Tax Disclosure [Text Block] |
Tax Expense and Tax Rate. three months ended March 31, 2020 and 2019 was $6.5 million and $0.2 million, respectively. For the three months ended March 31, 2020, our effective tax rate primarily differed from the statutory Federal tax rate for adjustments recorded related to the enactment of the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”) on March 27, 2020. The CARES Act modified certain income tax statutes, including changes related to the business interest expense limitation under Code Section 163 (j). For the three months ended March 31, 2019, immaterial deferred income tax expense was recorded due to dollar-for-dollar offsets by our valuation allowance. Our effective tax rate was 9.0% for the three months ended March 31, 2020 and was not meaningful for the three months ended March 31, 2019.
Valuation Allowance. not that some portion or all of them will not be realized. As of March 31, 2020 and December 31, 2019, our valuation allowance was $47.8 million and $54.4 million, respectively, and relates primarily to state net operating losses and the disallowed interest limitation carryover. Income Taxes Receivable. March 31, 2020 and December 31, 2019, we had current income taxes receivable of $1.9 2017 that was carried back to prior years. During the three months ended March 31, 2020 and 2019, we did not receive any income tax claims or make any income tax payments of significance.The tax years
2016 through 2019 remain open to examination by the tax jurisdictions to which we are subject. |